Lack of Association between Anti-Phospholipid Antibodies (APLA) and Attention Deficit/Hyperactivity Disorder (ADHD) in Children

Clinical and Developmental Immunology

Volumn 10, Issue 2-4, 2003, Pages 105-109

  Bujanover, Shay ^a,b   Levy, Yair ^a,b   Katz, Miriam ^a,b   Leitner, Yael ^b,c   Vinograd, Isaac ^b,c   Shoenfeld, Yehuda ^a,b,d  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d Incumbent L S K Chair Autoimmun ^*  (Israel)

Author keywords

Antiphospholipid Antibodies (APLA); Antiphospholipid Syndrome (APS); Attention Deficit Hyperactivity Disorder (ADHD); Children

Indexed keywords

ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; ETHANOLAMINE ANTIBODY; PHOSPHATIDYLSERINE ANTIBODY; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY SCREENING; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL;

ADOLESCENT; ANTIBODIES, ANTIPHOSPHOLIPID; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BETA 2-GLYCOPROTEIN I; CARDIOLIPINS; CHILD; CHILD, PRESCHOOL; ETHANOLAMINE; FEMALE; GLYCOPROTEINS; HUMANS; MALE; PHOSPHATIDYLSERINES;

EID: 0345872122     PISSN: 17402522     EISSN: None     Source Type: Journal    
DOI: 10.1080/10446670310001626553     Document Type: Article

References (23)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th Edn. (American Psychiatric Association, Washington DC).
2. Avcin, T., Ambrozic, A., Kuhar, M., et al. (2001) "Anticardiolipin and anti-B2 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits", Rheumatology 40, 565-573.
3. Biederman, J. and Spencer, T.J. (2000) "Genetics of childhood disorders: XIX. ADHD, part 3: Is ADHD a noradrenergic disorder?", J. Am. Acad. Child. Adolesc. Psychiatry 39, 1330-1333.
4. Brey, R.L., Escalante, A., Futrell, N. and Asherson, R.A. (1996) "Cerebral thrombosis and other neurological manifestations in the antiphospholipid syndrome", In: Adherson, R.A., Cervera, R., Piette, J.C. and Shoenfeld, Y., eds, The Antiphospholipid Syndrome (CRC Press, Boca Raton), pp 133-146.
5. Cantwell, D.P. (1996) "Attention deficit disorder: a review of the past 10 years", J. Am. Acad. Child. Adolesc. Psychiatry 35, 978-987.
6. Caronti, B., Pittoni, V., Palladini, G. and Valesini, G. (1998) "Anti-B2-glycoprotein I antibodies bind to central nervous system", J. Neurol. Sci. 156, 211-219.
7. Chapman, J., Cohen-Armon, M., Shoenfeld, Y. and Korczyn, A.D. (1999) "Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes", Lupus 88, 127-133.
8. Elia, J., Ambrosini, P.J. and Rapaport, J.L. (1999) "Treatment of attention deficit hyperactivity disorder", N. Engl. J. Med. 340, 780-788.
9. Eriksson, K., Peltola, J., Keranen, T., et al. (2001) "High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases", Epilepsy Res. 46, 129-137.
10. Goodman, R. and Stevenson, J. (1989) "A twin study of hyperactivity-II. The aetiological role of genes, family relationships, and perinatal adversity", J. Child Psychol. Psychiatry 30, 691-709.
11. Hojnik, M., George, J., Ziporen, L. and Shoenfeld, Y. (1996) "Heart valve involvement (Libman-Sacks endocarditis) in the phospholipid syndrome", Circulation 93, 1579-1587.
12. Hughes, G.R.V. (1983) "Thrombosis, abortion, cerebral disease and lupus anticoagulant", Br. Med. J. 187, 1088-1089.
13. Kent, M.N., Alvarez, F.J., Vogt, E., et al. (1997) "Monoclonal antiphospholipid antibodies react directly with feline and murine central nervous system", J. Rheumatol. 24, 1725-1733.
14. Kent, M., Alvarez, F.J., Ng, A.K. and Rote, N.S. (2000) "Ultrastructural localization of monoclonal antiphospholipid antibody binding to rat brain", Exp. Neurol. 163, 173-179.
15. Markus, H.S. and Hopkinson, N. (1992) "Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids", J. Neurol. 239, 39.
16. Robinson, L.M., Sclar, D.A., Skaer, T.L. and Galin, R.S. (1999) "National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children", Clin. Pediatr. 38, 209-217.
17. Segman, R.H., Meltzer, A., Gross-Tsur, V., et al. (2002) "Preferential transmission of interleukin 1 receptor antagonist alleles in attention deficit hyperactivity disorder", Mol. Psychiatry 7, 72-74.
18. Shuaib, A., Barklay, L., Lee, M.A. and Suchowersky, O. (1989) "Migraine and antiphospholipid antibodies", Headache 29, 42.
19. Tietjen, G.E., Day, M., Norris, L., et al. (1998) "Role of anticardiolipin antibodies in young persons with migraines and transient focal neurological events", Neurology 50, 1433.
20. Todd, R.D. and Botteron, K.N. (2001) "Is attention- deficit/hyperactivity disorder an energy deficiency syndrome?", Biol. Psychiatry 50, 151-158.
21. Verrotti, A., Cieri, F., Pelliccia, P., et al. (2001) "Lack of association between antiphospholipid antibodies and migranes in children", Int. J. Clin. Lab. Res. 30, 109-111.
22. Yoshimura, K., Konishi, T., Kotani, H., et al. (2001) "Prevalence of positive anticardiolipin antibodies in benign infantile convulsion", Brain Dev. 23, 317-320.
23. Ziporen, L., Shoenfeld, Y., Levy, Y. and Korczyn, A. (1997) "Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies", J. Clin. Investig. 100, 613-619.